Indication: Intra-Abdominal Infection

Multiple dose pharmacokinetic study of Meropenem in young infants (<91 days) with supected or compliated Intra-abdominal infections.

Sub-indication: Intra-Abdominal Infection

Drug Study

Principal Investigator: Janice Sullivan, M.D.
Norton Children's Critical Care, affiliated with the UofL School of Medicine

Sponsor: National Institutes of Health / Children

Search our entire site.